Rate My Professor Kelly Chibale

Professor Kelly Chibale is a full Professor of Organic Chemistry at the University of Cape Town, where he holds the Neville Isdell Chair in African-centric Drug Discovery & Development. He obtained a B.Sc. Ed. from the University of Zambia in 1987 and a PhD in Synthetic Organic Chemistry from the University of Cambridge in 1992. He completed postdoctoral research at the University of Liverpool and The Scripps Research Institute before joining the University of Cape Town as a contract lecturer in 1996, progressing through lecturer, senior lecturer, and associate professor roles to become a full professor in 2007. He is the founder and director of the Holistic Drug Discovery and Development (H3D) Centre at UCT, founding director of the South African Medical Research Council Drug Discovery and Development Research Unit, and a full member of the UCT Institute of Infectious Disease and Molecular Medicine. His research focuses on medicinal chemistry programmes targeting malaria, tuberculosis, helminth infections, and cardiovascular disease, with objectives including the development of target-directed inhibitors, progression of screening hits to leads, generation of diversity in natural products, characterization of reactive metabolites, and repurposing of clinical compounds. He has held visiting positions including as a US Fulbright Senior Research Scholar at the University of Pennsylvania School of Medicine and a Visiting Professor at Pfizer Global Research & Development. Professor Chibale has received numerous awards and honours, including the South African Medical Research Council Gold Medal in 2016, the South African Chemical Institute Gold Medal in 2018, the Royal Society Africa Prize in 2023, election as an international member of the United States National Academy of Sciences in 2025, an Honorary Doctorate from Leiden University in 2025, and selection as an American Society of Tropical Medicine and Hygiene Distinguished International Fellow in 2025. He was named one of Fortune magazine’s World’s 50 Greatest Leaders in 2018 and serves as Editor-in-Chief of ACS Medicinal Chemistry Letters. He is also a Schmidt Sciences AI2050 Senior Fellow.